Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -527.5% | -435.2% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | 6.6 |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | 30.9% | 7.1% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 0.76 | (13.74) | (6.51)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1.01 | (17.36) | (6.66)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1.04 | (24.44) | (8.96)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 2.19 | (21.63) | (7.72)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 2.86 | (15.03) | (4.82)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3.07 | (13.34) | (4.18)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 4.21 | (12.43) | (3.89)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 7.00 | (11.00) | (3.59)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
ANGLE announces collaboration with Myriad Genetics | 20-Aug-2025 | 07:00 | RNS |
Result of 2025 Annual General Meeting | 30-Jun-2025 | 17:50 | RNS |
POSTING OF ANNUAL REPORT AND NOTICE OF AGM | 09-Jun-2025 | 07:00 | RNS |
Angle reviewing board structure as two directors... | 06-Jun-2025 | ShareCast |
Angle slumps on cautious outlook | 28-May-2025 | ShareCast |
Angle completes assay development projects | 21-Mar-2025 | ShareCast |
New Angle for Braveheart | 26-Jan-2009 | The Scotsman |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 6.50p |
Change Today | 0.25p |
% Change | 4.00 % |
52 Week High | 16.50 |
52 Week Low | 5.00 |
Volume | 678,645 |
Shares Issued | 322.64m |
Market Cap | £20.97m |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
17:05 | 55,000 @ 6.50p |
14:25 | 10,265 @ 6.78p |
14:15 | 19,019 @ 6.83p |
13:37 | 5,010 @ 6.33p |
13:35 | 235 @ 7.00p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research